Log in

NYSEAMERICAN:XTNTXtant Medical Stock Price, Forecast & News

$0.97
-0.01 (-1.02 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.96
Now: $0.97
$1.07
50-Day Range N/A
52-Week Range
$0.55
Now: $0.97
$3.50
Volume71,100 shs
Average Volume345,766 shs
Market Capitalization$12.83 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DMB Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:XTNT
CUSIPN/A
Phone+1-406-3880480

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees141
Market Cap$12.83 million
Next Earnings Date8/13/2020 (Estimated)
OptionableNot Optionable

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

When is Xtant Medical's next earnings date?

Xtant Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Xtant Medical.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) announced its quarterly earnings results on Thursday, May, 7th. The medical device company reported ($0.19) EPS for the quarter. The medical device company earned $14.78 million during the quarter. View Xtant Medical's earnings history.

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Shares of Xtant Medical reverse split on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

Has Xtant Medical been receiving favorable news coverage?

Media coverage about XTNT stock has been trending somewhat negative this week, according to InfoTrie. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Xtant Medical earned a media sentiment score of -1.3 on InfoTrie's scale. They also gave media coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Xtant Medical.

Are investors shorting Xtant Medical?

Xtant Medical saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 781,200 shares, an increase of 5,955.8% from the May 31st total of 12,900 shares. Based on an average trading volume of 645,900 shares, the days-to-cover ratio is presently 1.2 days. Approximately 6.4% of the company's stock are sold short. View Xtant Medical's Current Options Chain.

Who are some of Xtant Medical's key competitors?

What other stocks do shareholders of Xtant Medical own?

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the following people:
  • Mr. Sean E. Browne, Pres ,CEO & Director (Age 54, Pay $665.08k)
  • Mr. Greg Jensen, VP of Fin., CFO & Principal Financial and Accounting Officer (Age 59, Pay $544.16k)
  • Mr. Kevin D. Brandt, Sr. VP & Chief Commercial Officer (Age 54, Pay $629.65k)
  • Ms. Catherine Lundy, VP of HR
  • Mr. Kevin M. O'Dare, VP of Sales - Eastern US

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $0.97.

How big of a company is Xtant Medical?

Xtant Medical has a market capitalization of $12.83 million. Xtant Medical employs 141 workers across the globe.

What is Xtant Medical's official website?

The official website for Xtant Medical is xtantmedical.com.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at +1-406-3880480.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.